Minoryx Therapeutics S.l.

Marc Revés Vilaplana

Ana Maria García Collazo

Xavier Barril Alonso

Richard Spurring Roberts

Elena Cubero Jordà

The application is directed to compounds of formula (I): and their salts and solvates, wherein R, R, R, A, A, A, and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of a lysosomal storage disease, such as Gaucher's, and other diseases or disorders that are synucleinopathies.

Heteroaryl compounds and their use

The application is directed to compounds of formula (I): and their salts and solvates, wherein R, R, R, A, A, A, and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of a lysosomal storage disease, such as Gaucher's, and other diseases or disorders that are synucleinopathies. 

Growing community of inventors

Barcelona, Spain

Marc Revés Vilaplana